The Korean Journal of Hospice and Palliative Care

Survival Time (Days) according to Patients’ Characteristics (N=67).

No. of patients Median (interquartile range) P*
Age (yr) 0.120
<75 35 4 (3~8)
≥75 32 6 (3~10)
Sex 0.179
Male 37 7 (3~11)
Female 30 4 (3~7)
ECOG performance status 0.996
≤2 13 5 (5~8)
3 24 5 (3~10)
4 26 4 (3~9)
Antibiotic use 0.640
No 35 4 (3~10)
Yes 32 7 (3~9)
White blood cell (103/mm3) 0.655
<10 22 4 (3~11)
≥10 45 5 (3~8)
Hemoglobin (g/dL) 0.129
≥13 15 7 (4~15)
<13 52 5 (3~8)
Platelet (103/mm3) 0.480
≥150 47 5 (3~9)
<150 20 4 (3~10)
Serum creatinine level (mg/dL) 0.040
≤1.2 47 6 (3~10)
>1.2 20 3 (3~8)
Albumin (g/dL) 0.214
≥3.5 12 4 (2~13)
<3.5 55 5 (3~9)
Total bilirubin (mg/dL) 0.188
<1.2 48 5 (3~10)
≥1.2 19 4 (3~9)
Prolonged PT INR 0.516
≤1.2 35 5 (3~10)
>1.2 31 6 (3~9)
C-reactive protein level (mg/dL) 0.347
≤14.5 33 5 (3~11)
>14.5 34 6 (3~9)
D-dimer (μg/mL) 0.012
<1.5 33 7 (4~13)
≥1.5 34 4 (3~7)

ECOG: Eastern Cooperative Oncology Group, PT INR: prothrombin time international normalized ratio.

From the log-rank test, Using the median value.

Korean J Hosp Palliat Care 2020;23:11~16 https://doi.org/10.14475/kjhpc.2020.23.1.11
© Korean J Hosp Palliat Care